Furthermore, the mechanistic insights presented in this work indicate that direct stabilization of LCMT1 by phosphorylation-targeting chimeras (PhosTACs)77 based therapeutics could provide additional opportunity for targeted activation of methyl-sensitive biased PP2A heterotrimers in treating transcription addicted cancers. This evidence concerns the gene LCMT1 and cancer.